About Kalvista Pharma (KALV)
KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of disease... Read more
- USD10.12
- USD10.52
- USD10.11
- USD16.88
- -12.70%
- --
- 363.77k
- 439.17k
- 488M
- 7.21
- 29.10%
Stock News
47 minutes ago
Bristol Myers Squibb stock tumbles on cost-cutting initiative
Yahoo
52 minutes ago
Alphabet stock pops off on Q1 earnings beat, cash dividend
Yahoo
54 minutes ago
H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024
Yahoo
59 minutes ago
Cigna to offer Humira rivals with $0 copay at specialty pharmacy
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
